Inobrodib (CCS-1477) Mechanism of Action: p300/CBP Inhibition in Plasma Cell Research

Inobrodib (CCS-1477) MOA:Targeting p300/CBP / MYC Pathway for Multiple Myeloma

🎯 check Inobrodib (CCS-1477) product page

Inobrodib (CCS-1477) is a potent p300/CBP inhibitor. It affects HEXIM1 signaling, by blocking p300/CBP, inhibiting tumor growth.

Primary Applications and Mechanism of Action